Hollencrest Capital Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-28
Closed -$2.12K 1294
2026
Q1
$2.12K Hold
28
﹤0.01% 1017
2025
Q4
$2.09K Sell
28
-100
-78% -$7.31K ﹤0.01% 1012
2025
Q3
$8.64K Hold
128
﹤0.01% 819
2025
Q2
$8.34K Hold
128
﹤0.01% 797
2025
Q1
$7.91K Sell
128
-2
-2% -$133 ﹤0.01% 806
2024
Q4
$9.37K Buy
130
+100
+333% +$7.81K ﹤0.01% 803
2024
Q3
$2.44K Buy
30
+2
+7% +$160 ﹤0.01% 934
2024
Q2
$2.08K Hold
28
﹤0.01% 925
2024
Q1
$2.18K Hold
28
﹤0.01% 889
2023
Q4
$2K Hold
28
﹤0.01% 892
2023
Q3
$1.94K Hold
28
﹤0.01% 922
2023
Q2
$2.27K Hold
28
﹤0.01% 951
2023
Q1
$2.26K Hold
28
﹤0.01% 946
2022
Q4
$2.1K Buy
+28
New +$1.99K ﹤0.01% 940

Other funds holding HOLX

Hollencrest Capital Management's HOLX Position: Q2 2026 in Review

Hollencrest Capital Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 28 shares — an estimated $2.12K sold.

Hollencrest Capital Management first reported a position in HOLX in Q4 2022 and held it in 14 quarters. The position peaked at $9.37K in Q4 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Hollencrest Capital Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Hollencrest Capital Management sold 28 Hologic shares in Q2 2026, an estimated $2.12K.
  • Hollencrest Capital Management first reported a position in Hologic in Q4 2022 and held it in 14 quarters.
  • Hollencrest Capital Management's Hologic position peaked at $9.37K in Q4 2024.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Hollencrest Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.